Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ashraf Omar, MD"'
Autor:
Devika Sindu, MD, Deepika Razia, MD, Katherine Grief, RN, MSN, Lauren Cherrier, MD, Ashraf Omar, MD, Rajat Walia, MD, Sofya Tokman, MD
Publikováno v:
Transplantation Direct, Vol 9, Iss 6, p e1485 (2023)
Background. Lung transplant recipients (LTRs) have an increased risk of COVID-19–related morbidity and mortality. Tixagevimab-cilgavimab (tix-cil) is a long-acting monoclonal antibody combination granted Emergency Use Authorization approval by the
Externí odkaz:
https://doaj.org/article/d25a937585bc4a1fbbf256d2bd1699f1
Autor:
Paul N. Banks, MA, Ashraf Omar, MD, Rajat Walia, MD, Sarabjit Bhalla, MD, Yun Chong, MD, Sofya Tokman, MD
Publikováno v:
Transplantation Direct, Vol 4, Iss 4, p e359 (2018)
Background. Lung transplant recipients are treated with a 3-drug immunosuppressive regimen that consists of a calcineurin inhibitor, an antiproliferative agent, and a corticosteroid. Calcineurin inhibitors are the backbone of this regimen, and tacrol
Externí odkaz:
https://doaj.org/article/ce5d0cd685bf480eb43c64f09c2ee5b5
Autor:
Sanaa Mahmoud MD, PhD, Eman M Fouda MD, PhD, Alyaa Kotby MD, PhD, Hanan M Ibrahim MD, PhD, Mervat Gamal MD, PhD, Yasmin G el Gendy MD, Eman Ahmed Zaky MD, PhD, Nermine H Amr MD, PhD, FRCPCH, Dalia H El-Ghoneimy MD, PhD, Asmaa AA Alsharkawy MD, PhD, Ashraf Omar MD, PhD, Mahmoud El-Meteini MD, PhD, Mostafa Elhodhod MD, PhD
Publikováno v:
Global Pediatric Health, Vol 8 (2021)
The global concern of increasing number of children presenting with multisystem inflammatory syndrome in children (MIS-C) related to the coronavirus disease (COVID-19) has escalated the need for a case-oriented clinical approach that provides timely
Externí odkaz:
https://doaj.org/article/055cffa67d85448ea85c8f2db10ee421